Highlights Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
2.75 ^USD	+0.73%		+4.56%	-32.76%

May. 13	Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating	MT
May. 10	Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup	DJ

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup	May. 10	DJ
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q1 Revenue $110M, vs. Street Est of $101.1M	May. 09	MT
Organogenesis Holdings Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2024	May. 09	CI
Organogenesis Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis	May. 02	CI
Organogenesis Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q4 Revenue $99.7M, vs. Street Est of $109.1M	Feb. 29	MT
Organogenesis Holdings Inc. Provides Earnings Guidance for the First Quarter and for the Year Ending December 31, 2024	Feb. 29	CI
Organogenesis Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q3 Revenue $108.5M, vs. Street Est of $111.4M	Nov. 09	MT
Organogenesis Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Organogenesis Holdings Inc. Provides Earnings Guidance for the Year Ending December 31, 2023	Nov. 09	CI
Advanced Medical issues profit warning following royalty issues	23-09-04	AN
Advanced Medical Solutions Group Updates FY23 Guidance	23-09-04	MT
Organogenesis Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q2 Revenue $117.3M, vs. Street Est of $115.1M	23-08-09	MT
Organogenesis Holdings Inc. Withdraws Earnings Guidance for the the 2023	23-08-09	CI
Organogenesis Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Reports Q1 Revenue $107.6M	23-05-10	MT
Organogenesis Holdings Inc. Provides Earnings Guidance for the Fiscal Year 2023	23-05-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Highlights

Filters